ITEM 1. FINANCIAL STATEMENTS AND EXHIBITS |
PAGE NUMBER
|
||
|
|||
(a)
|
Financial Statements
|
|
|
|
|
|
|
|
1. Report of Independent Registered Public Accounting Firm |
F-S 1
|
|
|
|
|
|
|
2. Statements of Net Assets Available for Benefits at |
F-S 2
|
|
|
December 31, 2019 and 2018
|
|
|
|
|||
|
3. Statements of Changes in Net Assets Available for Benefits |
F-S 3
|
|
|
For the Year Ended December 31, 2019 |
|
|
|
|
|
|
4. Notes to Financial Statements |
F-S 4 through F-S 10
|
||
|
|||
5. Schedule: |
|
||
|
Schedule I – Schedule of Assets (Held At End of Year)
|
F-S 11
|
|
|
|||
6. Consent of Independent Registered Public Accounting Firm |
Exhibit I
|
Dated: June 18, 2020 | CHEMED/ROTO-ROOTER SAVINGS & RETIREMENT PLAN | ||
By:
|
/s/ Michael R. Dibowski | ||
Michael R. Dibowski | |||
Administrative Committee |
December 31,
|
||||||||
2019
|
2018
|
|||||||
Assets:
|
||||||||
Investments, at fair value:
|
||||||||
Chemed Corporation common stock
|
$
|
39,663,222
|
$
|
29,288,373
|
||||
Mutual funds
|
231,379,036
|
177,688,110
|
||||||
Collective Trust fund
|
9,588,410
|
9,999,899
|
||||||
Total investments
|
280,630,668
|
216,976,382
|
||||||
Receivables:
|
||||||||
Notes receivable from participants
|
8,214,284
|
7,094,073
|
||||||
Employer contributions
|
4,645,638
|
4,860,323
|
||||||
Participant contributions
|
248,318
|
209,089
|
||||||
Accrued interest and dividends
|
2,697
|
1,603
|
||||||
Total receivables
|
13,110,937
|
12,165,088
|
||||||
Cash
|
-
|
111,930
|
||||||
Total assets
|
293,741,605
|
229,253,400
|
||||||
Liabilities:
|
||||||||
Other liabilities
|
153,198
|
-
|
||||||
Accrued expenses
|
3,666
|
2,370
|
||||||
Net assets available for benefits, at fair value
|
$
|
293,584,741
|
$
|
229,251,030
|
Year Ended
|
||||
December 31, 2019
|
||||
Contributions:
|
||||
Employer
|
$
|
9,356,368
|
||
Participant
|
12,090,660
|
|||
Rollovers
|
7,135,646
|
|||
28,582,674
|
||||
Interest income on notes receivable from participants |
417,271
|
|||
|
||||
Investment income:
|
||||
Net realized and unrealized gain on investments
|
47,362,271
|
|||
Dividends and other income
|
9,893,115
|
|||
57,255,386
|
||||
Benefits paid to participants
|
(21,756,858
|
)
|
||
Administrative expenses
|
(164,762
|
)
|
||
(21,921,620
|
)
|
|||
Increase in net assets
|
64,333,711
|
|||
Net assets available for benefits:
|
||||
Beginning of year
|
229,251,030
|
|||
End of year
|
$
|
293,584,741
|
2. |
Summary of Significant Accounting Policies
|
3. |
Tax Status
|
4. |
Reconciliation of Financial Statements to Form 5500
|
December 31,
|
||||||||
2019
|
2018
|
|||||||
Net assets available for benefits per
|
||||||||
the financial statements
|
$
|
293,584,741
|
$
|
229,251,030
|
||||
Amounts allocated to withdrawing
|
||||||||
participants
|
(261,038
|
)
|
(108,520
|
)
|
||||
Net assets available for benefits per
|
||||||||
the Form 5500
|
$
|
293,323,703
|
$
|
229,142,510
|
Increase in net assets per the financial statements
|
$
|
64,333,711
|
||
Less: Change in amounts allocated to withdrawing particpants
|
(152,518
|
)
|
||
Net income per Form 5500
|
$
|
64,181,193
|
Investments
|
December 31, 2019
|
|||||||||||||||
(at fair value)
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
Common stock
|
$
|
39,663,222
|
$
|
39,663,222
|
$
|
-
|
$
|
-
|
||||||||
Mutual funds
|
231,379,036
|
231,379,036
|
-
|
-
|
||||||||||||
Total
|
$
|
271,042,258
|
$
|
-
|
$
|
-
|
||||||||||
Investments measured at NAV:
|
||||||||||||||||
Collective trust fund
|
9,588,410
|
|||||||||||||||
Total investments at fair value
|
$
|
280,630,668
|
||||||||||||||
Investments
|
December 31, 2018
|
|||||||||||||||
(at fair value)
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
Common stock
|
$
|
29,288,373
|
$
|
29,288,373
|
$
|
-
|
$
|
-
|
||||||||
Mutual funds
|
177,688,110
|
177,688,110
|
-
|
-
|
||||||||||||
Total
|
$
|
206,976,483
|
$
|
-
|
$
|
-
|
||||||||||
Investments measured at NAV:
|
||||||||||||||||
Collective trust fund
|
9,999,899
|
|||||||||||||||
Total investments at fair value
|
$
|
216,976,382
|
December 31, 2019
|
Schedule I |
(e) | ||||||||
(a)
|
(b)
|
(c)
|
Current
|
|||||
Identity of issue
|
Description of investment
|
value
|
||||||
Chemed Corporation common stock
|
||||||||
*
|
Chemed Corporation
|
Common Stock
|
$
|
39,663,222
|
||||
Mutual funds
|
||||||||
iShares
|
S&P 500 Index Fund
|
34,282,798
|
||||||
MFS
|
International Intrinsic Value Fund
|
31,869,336
|
||||||
T Rowe Price
|
Blue Chip Growth Fund
|
26,432,712
|
||||||
JP Morgan
|
Core Bond Fund
|
23,498,883
|
||||||
Vanguard
|
Federal Money Market Fund
|
19,028,408
|
||||||
BlackRock
|
Equity Dividend Fund
|
18,232,932
|
||||||
Victory Sycamore
|
Established Value Fund
|
17,823,354
|
||||||
Hartford
|
Mid Cap Growth
|
15,830,682
|
||||||
MFS
|
Total Return Fund
|
11,196,071
|
||||||
Columbia
|
Small Cap Value Fund
|
6,263,145
|
||||||
PIMCO
|
Real Return Fund
|
6,106,764
|
||||||
Wells Fargo
|
Short Duration Government Bond Fund
|
6,007,047
|
||||||
Invesco Oppenheimer
|
International Small-Mid Company Fund
|
5,856,312
|
||||||
Lord Abbett
|
Developing Growth Fund
|
5,147,436
|
||||||
Oakmark
|
Equity & Income Fund
|
3,803,156
|
||||||
Total mutual funds
|
231,379,036
|
|||||||
Collective Trust fund
|
||||||||
Invesco
|
Stable Value Retirement Fund
|
9,588,410
|
||||||
Notes receivable from participants
|
||||||||
*
|
Loan Fund
|
Loans to Participants, at rates ranging from
|
||||||
4.25% to 7.50%
|
8,214,284
|
|||||||
Total
|
$
|
288,844,952
|
||||||
*
|
Denotes party in interest.
|